Published in Cancer Weekly, March 18th, 2003
Mary Ann (MD, PhD) and Donald (PhD) Sens, a husband-and-wife research team at the University of North Dakota School of Medicine and Health Sciences, say that when some types of cancer cells overproduce a specific protein, the information can be used to determine the cancer's stage of development and how aggressively to treat it.
The Sens' two cancer research projects - both funded by the U.S. National Institutes of Health (NIH) - relate to a protein called...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.